Brad Middlekauff is the Senior Vice President, General Counsel and Secretary of Edge Therapeutics, Inc. Most recently, Mr. Middlekauff served as Executive in Residence at Princeton University. Previously, Mr. Middlekauff was Chief Legal Officer, General Counsel and Secretary at Kolltan Pharmaceuticals, Inc., where he also ran the business development function and Senior Vice President, General Counsel and Secretary of Medarex, Inc. Mr. Middlekauff was an associate with the law firm of Cooley Godward, where he advised life science companies on a broad range of business and legal matters.
Mr. Middlekauff has served as Chairman of the Biotechnology Industry Organization (BIO) General Counsels’ Committee and Vice President of the Yale Law School Executive Committee and has spoken at numerous conferences on legal and business issues relating to biotechnology.
Mr. Middlekauff received a bachelor’s degree from Brown University and a law degree from Yale Law School.